about
The cyanobacterial origin of potent anticancer agents originally isolated from sea hares.Macrolactone Nuiapolide, Isolated from a Hawaiian Marine Cyanobacterium, Exhibits Anti-Chemotactic ActivityHalogenated fatty acid amides and cyclic depsipeptides from an eastern Caribbean collection of the cyanobacterium Lyngbya majusculaTRPM7 Regulates Axonal Outgrowth and Maturation of Primary Hippocampal Neurons.TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cellsThe coiled-coil domain of zebrafish TRPM7 regulates Mg·nucleotide sensitivity.Scalaradial Is a Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels.Antimicrobial effects of marine algal extracts and cyanobacterial pure compounds against five foodborne pathogens.Isolation and structure determination of malevamide E, a dolastatin 14 analogue, from the marine cyanobacterium Symploca laete-viridis.The TRPM7 channel kinase regulates store-operated calcium entry.Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR.Validation of ATR FT-IR to identify polymers of plastic marine debris, including those ingested by marine organismsIsolation and structure elucidation of ardisenone: a new, cytotoxic alkenylphenol from Ardisia iwahigensisA new depsipeptide from the sacoglossan mollusk Elysia ornata and the green alga Bryopsis speciesMalevamides A-C, new depsipeptides from the marine cyanobacterium Symploca laete-viridisMalevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoidesIsolation of gallic acid esters as antiplasmodial constituents of Swintonia foxworthyi (Anacardiaceae)Isolation, Structure Determination, and Synthesis of Cyclic Tetraglutamic Acids from Box Jellyfish Species Alatina alata and Chironex yamaguchii
P50
Q34946350-F0C56AEA-610C-462F-99D3-6D53FCC4E50FQ36226759-CD52BA64-BFAC-4484-A66C-692A3AF98450Q36434725-F6E2239E-89D6-4693-88EA-E853DCA28C11Q36764074-93A40828-473C-4BE5-BD7B-F3FF54AA219AQ37017069-B6699015-E006-4FBE-858F-75097E7243EAQ41098978-9C40C8F4-60E5-40C3-B9E8-A757C2183CEFQ46289087-C806C2A7-1936-4058-A2A8-78A8A44A95FFQ46609787-3BE17014-2D49-4C7C-AFE4-B939BFA1CBD7Q46686546-5707670F-3C62-4994-A100-4160E12F4122Q48301938-680EBC52-FFB5-4C66-9337-2A66B20E1AD5Q55030853-C484D4E2-41C2-44AC-AF6C-23EE9545752AQ61459100-042692AF-A493-476E-8D54-2C4A03AF0C93Q73384458-6EF22003-A58C-42C4-8E84-67077AFF56ADQ73390637-EF0B74B3-46AC-4343-B707-45A5E6EF7E4FQ73721055-8AB70E84-C30E-4852-9AD6-BCAE31DE5874Q78007365-AE91F8F1-8F72-430C-B5F8-F98254683B0BQ85571682-6678D530-B7A5-4F8B-9360-DE58143C68E6Q89805557-2CD0A223-12B4-4C45-A0A3-59E823417B28
P50
description
researcher
@en
name
F. David Horgen
@en
Horgen FD
@nl
type
label
F. David Horgen
@en
Horgen FD
@nl
altLabel
Horgen FD
@en
prefLabel
F. David Horgen
@en
Horgen FD
@nl
P106
P31
P496
0000-0001-9409-3030